REVB
Price
$2.78
Change
+$0.05 (+1.83%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
4.74M
TCRT
Price
$2.12
Change
+$0.23 (+12.17%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
4.15M
Interact to see
Advertisement

REVB vs TCRT

Header iconREVB vs TCRT Comparison
Open Charts REVB vs TCRTBanner chart's image
Revelation Biosciences
Price$2.78
Change+$0.05 (+1.83%)
Volume$109
Capitalization4.74M
Alaunos Therapeutics
Price$2.12
Change+$0.23 (+12.17%)
Volume$400
Capitalization4.15M
REVB vs TCRT Comparison Chart in %
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. TCRT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a StrongBuy and TCRT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (REVB: $2.73 vs. TCRT: $1.89)
Brand notoriety: REVB and TCRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 36% vs. TCRT: 20%
Market capitalization -- REVB: $4.74M vs. TCRT: $4.15M
REVB [@Biotechnology] is valued at $4.74M. TCRT’s [@Biotechnology] market capitalization is $4.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green whileTCRT’s FA Score has 0 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • TCRT’s FA Score: 0 green, 5 red.
According to our system of comparison, REVB is a better buy in the long-term than TCRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 5 TA indicator(s) are bullish while TCRT’s TA Score has 3 bullish TA indicator(s).

  • REVB’s TA Score: 5 bullish, 4 bearish.
  • TCRT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, REVB is a better buy in the short-term than TCRT.

Price Growth

REVB (@Biotechnology) experienced а +7.91% price change this week, while TCRT (@Biotechnology) price change was -8.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REVB($4.74M) has a higher market cap than TCRT($4.15M). TCRT YTD gains are higher at: -0.787 vs. REVB (-87.663). TCRT has higher annual earnings (EBITDA): -3.9M vs. REVB (-8.08M). REVB has more cash in the bank: 5.17M vs. TCRT (2.88M). REVB (0) and TCRT (0) have identical debt. TCRT has higher revenues than REVB: TCRT (6K) vs REVB (0).
REVBTCRTREVB / TCRT
Capitalization4.74M4.15M114%
EBITDA-8.08M-3.9M207%
Gain YTD-87.663-0.78711,133%
P/E Ratio0.00N/A-
Revenue06K-
Total Cash5.17M2.88M180%
Total Debt00-
FUNDAMENTALS RATINGS
TCRT: Fundamental Ratings
TCRT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REVBTCRT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
52%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZH4.900.27
+5.83%
Zhihu
UNCY4.270.02
+0.47%
Unicycive Therapeutics Inc
ENVX10.520.03
+0.29%
Enovix Corp
BBLG2.15-0.01
-0.46%
Bone Biologics Corp
RGLD176.97-0.92
-0.52%
Royal Gold

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-2.08%
GNPX - REVB
48%
Loosely correlated
+1.89%
TCRT - REVB
46%
Loosely correlated
+1.07%
OGEN - REVB
34%
Loosely correlated
-1.79%
IMUX - REVB
32%
Poorly correlated
-2.85%
TOVX - REVB
31%
Poorly correlated
-0.10%
More

TCRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
+1.07%
SNTI - TCRT
47%
Loosely correlated
-0.95%
REVB - TCRT
46%
Loosely correlated
-2.08%
BRTX - TCRT
33%
Loosely correlated
+2.35%
ALNY - TCRT
30%
Poorly correlated
+0.66%
KPRX - TCRT
29%
Poorly correlated
+0.67%
More